Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability

Yoshihiro Fukui

Publications
  • Research Article
    Assessment of Ethnic Differences in the Pharmacokinetics and Pharmacodynamics of Valsartan
    Author(s): Gangadhar Sunkara, ChingMing Yeh, Monica Ligueros-Saylan, Hiroto Kawashita, Nozomu Koseki and Yoshihiro FukuiGangadhar Sunkara, ChingMing Yeh, Monica Ligueros-Saylan, Hiroto Kawashita, Nozomu Koseki and Yoshihiro Fukui

    Objective: To assess the potential ethnic differences in pharmacokinetics and pharmacodynamics of valsartan between Japanese and Caucasian subjects. Methods: This was an open-label, parallel-design study conducted in male Japanese (n=15) and Caucasian (n=15) subjects with similar age and body weight. All subjects received a single oral dose of 160 mg valsartan capsule, and the plasma levels of valsartan, aldosterone, and angiotensin II along with plasma renin activity (PRA) were determined at pre-set time intervals, post-dosing. Key findings: The time to reach peak plasma concentrations of valsartan (T max ) was in the range of 1–6 h in both groups. The mean C max of valsartan was 3.3 and 3.6 μg/ml; the mean plasma exposure (AUC 0- ∞ ) values were 23.0 and 23.8 μg.h/ml and the mean half-life (t 1/2 ) was 7.7 and 9.6 h in Japanese and Caucasian subjects, respectively... View More»
    DOI: 10.4172/jbb.1000043

    Abstract PDF